About
Aprepitant is a highly selective neurokinin-1 (NK1) receptor antagonist, a novel class of antiemetic agents. Its mechanism of action involves blocking the binding of substance P, a key neuropeptide, to the NK1 receptor in the central nervous system, particularly in the area postrema. This blockade effectively inhibits both the acute and, crucially, the delayed phases of chemotherapy-induced nausea and vomiting (CINV), which are often difficult to control. Aprepitant is typically used as part of a multi-drug regimen, in combination with other antiemetic agents such as corticosteroids (e.g., dexamethasone) and 5-HT3 receptor antagonists (e.g., ondansetron), to provide comprehensive and enhanced control of emesis in patients receiving highly or moderately emetogenic chemotherapy. Its addition significantly improves the overall efficacy of antiemetic prophylaxis.
Uses
- Prevention of acute chemotherapy-induced nausea and vomiting.
- Prevention of delayed chemotherapy-induced nausea and vomiting.
- Used in combination with other antiemetics for highly emetogenic chemotherapy.
- Used in combination with other antiemetics for moderately emetogenic chemotherapy.
Directions For Use
Take orally with or without food, as directed by your doctor. Swallow the capsule whole.
Benefits
- Highly effective in preventing chemotherapy-induced nausea.
- Significantly reduces chemotherapy-induced vomiting.
- Covers both acute and delayed phases of CINV.
- Improves patient comfort during chemotherapy.
- Enhances the efficacy of other antiemetic drugs.
- Contributes to better adherence to chemotherapy regimens.
Side Effects
- Fatigue
- Dizziness
- Headache
- Hiccups
- Constipation
- Diarrhea
- Dyspepsia
- Anorexia
- Neutropenia
- Increased liver enzymes
- Hypotension
- Allergic reactions
Safety Measures
- Alcohol - No specific contraindication, but general health advice regarding alcohol consumption should be followed.
- Pregnancy - Use only if clearly needed and potential benefits outweigh risks; consult a doctor.
- Breastfeeding - Caution is advised; it is unknown if aprepitant is excreted in human milk.
- Liver - Use with caution in severe liver impairment; monitor patients closely.
- Kidney - No specific dose adjustment required for kidney impairment.
- Lung - Generally safe for use in patients with lung conditions.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!